Utilizing the Molecular/Physiologic Phenotype to Direct Asthma Therapy: A Comprehensive Infographic View
Barbara P. Yawn, MD, MSc, FAAFP
Director of Research,
Olmsted Medical Center
Adjunct Professor, Family and Community Health
University of Minnesota
This enduring activity will cover the diagnosis, treatment and management of patients with asthma and the correlation between asthma and nasal polyps.
This CME initiative is designed to meet the educational needs of pulmonologists, allergists, immunologists, ENTs and primary care physicians who are involved in the healthcare of patients with moderate-to-severe asthma.
Upon the completion of this program, attendees should be able to:
- Assess the causes of underlying inflammation in asthma and resulting targets of therapy
- Evaluate the level of asthma control, disease severity, and exacerbation risk to better drive appropriate treatment
- Review currently available and novel targeted therapies and their effect on treatment strategies for patients with moderate-to-severe asthma
ACCREDITATION AND DESIGNATION STATEMENTS
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med Learning Group designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with asthma.
1.0 ANCC Contact Hour(s)
CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME)
Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
In the last 12 months, Barbara P. Yawn, MD, MSc, FAAFP reported that she is a consultant/ independent contractor for AstraZeneca plc; GlaxoSmithKline plc; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd; Novartis; Grant/Research Support: Agency for Healthcare Research and Quality (AHRQ); National Institutes of Health (NIH); and Patient-Centered Outcomes Research Institute (PCORI).
The independent reviewers, staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have nothing to disclose.
Staff, Planners and Managers
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Brooke Hefele, Outcomes Coordinator for Med Learning Group has nothing to disclose.
Nina Oshiokpekhai, MS, PharmD, Medical Director for Med Learning Group has nothing to disclose.
Melissa A Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.
You will receive your certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement
information at http://medlearninggroup.com/privacy‐policy/
RELEASE: December 14, 2018
EXPIRE: December 14, 2019
Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.